AMTI Applied Molecular Transport Inc

-0.0187 (-9.9%)
Last Updated: 10:59:31
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 369,961
Bid Price 0.1703
Ask Price 0.1793
News -
Day High 0.1798


52 Week Range


Day Low 0.1701
Company Name Stock Ticker Symbol Market Type
Applied Molecular Transport Inc AMTI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0187 -9.9% 0.1702 10:59:31
Open Price Low Price High Price Close Price Prev Close
0.1778 0.1701 0.1798 0.1889
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
393 369,961 $ 0.1739368 $ 64,350 - 0.1507 - 1.39
Last Trade Time Type Quantity Stock Price Currency
10:56:23 1,200 $ 0.1702 USD

Applied Molecular Transport Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.71M 39.43M - 0 -126.33M -3.20 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Applied Molecular Transp... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No AMTI Message Board. Create One! See More Posts on AMTI Message Board See More Message Board Posts

Historical AMTI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.21650.28470.15070.19988615,878,342-0.0463-21.39%
1 Month0.2750.410.15070.21362483,170,725-0.1048-38.11%
3 Months0.27990.410.15070.21845731,097,699-0.1097-39.19%
6 Months0.390.48930.15070.2357299629,599-0.2198-56.36%
1 Year1.101.390.15070.3613665437,377-0.9298-84.53%
3 Years32.5878.220.150711.41314,931-32.41-99.48%
5 Years18.0678.220.150712.91318,760-17.89-99.06%

Applied Molecular Transp... Description

Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue.